Endoscopy/Anticoagulants and Antiplatelets/Gastrointestinal Bleeding

Endoscopy/Anticoagulants and Antiplatelets/Gastrointestinal Bleeding

The goal of this program is to improve efficiency in endoscopy centers, improve the management of anticoagulants and antiplatelet agents in the gastrointestinal (GI) setting, and improve management of acute lower GI bleeding (LGIB). After hearing and assimilating this program, the clinician will be better able to: 1. Use virtual simulation modeling to improve the efficiency of endoscopy centers. 2. Identify specific measures that improve the quality and efficiency of endoscopy centers. 3. Implement updated guidelines for managing antithrombotic agents during acute GI bleeding and routine endoscopic procedures. 4. Manage life-threatening LGIB in patients taking direct oral anticoagulants. 5. Analyze the recommended clinical guidelines for diagnosis and management of LGIB.

  • Provider:Lippincott Continuing Medical Education Institute, Inc.
  • Activity Link: https://www.audio-digest.org/Specialties/gastroenterology
  • Start Date: 2024-03-27 05:00:00
  • End Date: 2024-03-27 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
  • MOC Credit Details: ABIM - 2.0 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Yes
  • Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Gastroenterology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.